Impact of Corruption on the Peruvian Health System: A Systematic Review
DOI:
https://doi.org/10.33595/2226-1478.17.1550Keywords:
corruption, public health, health system, decision-makingAbstract
Corruption in healthcare represents a structural barrier that undermines equity, efficiency, and trust in the health system. In Peru, its effects are more critical in rural areas and during emergencies. The objective of this study was to determine how corruption in the Peruvian health system influences the decision-making of public health professionals regarding patient care. A qualitative and mixed-methods systematic review was conducted using six databases (2000–2024). Study selection was based on PEO criteria. Methodological quality was assessed using ENTREQ, CASP, and JBI-QARI, while confidence in the findings was evaluated with GRADE-CERQual. The analysis was thematic and comparative. Of the 28 studies identified, three met the inclusion criteria. The findings show that structural corruption limits the implementation of technologies, generates cost overruns in procurement, affects the sustainability of projects, and reduces institutional trust. Medical professionalism was identified as an indirect protective factor, although insufficient to prevent corrupt practices. It is concluded that corruption negatively impacts healthcare delivery and health management in Peru. The implementation of transparency policies, accountability mechanisms, and citizen participation is urgently needed.
Downloads
References
Arancibia, D., Silva, D., Cortés, F., & Muñoz, D. (2021). Vigilancia, investigación y evaluación en la gestión del riesgo del COVID-19. Los casos de Chile, Colombia, Ecuador y Perú . Religación, 6(27), 23-37. https://doi.org/10.46652/rgn.v6i27.770
Bellido-Boza, L., (2024). Cost-sharing and associated factors in the Peruvian private health sector. Revista Peruana de Medicina Experimental y Salud Pública, 41(1), 54–63. https://doi.org/10.17843/rpmesp.2024.411.13327
Botero-Rodríguez, F., Pantoja-Ruiz, C., & Rosselli, D. (2023). Corruption and its relation to prevalence and death due to noncommunicable diseases and risk factors: A global perspective. Revista Panamericana de Salud Pública, 46, e10.
Bressan, C., Loayza, R., Valer, J., Ruiz, A., Huicho, L., & Hartinger, S. M. (2022). Challenges of designing and implementing biomedical technologies in remote Peruvian Amazon communities: Lessons learned for effective implementation. International Journal for Equity in Health, 21(1), 157. https://doi.org/10.1186/s12939-022-01727-2
Cardoso, M. M. de A., (2024). Mapping frameworks for synthesizing qualitative evidence in health technology assessment. International Journal of Technology Assessment in Health Care, 40(1), e53. https://doi.org/10.1017/S0266462324000369
Contraloría General de la República. (2020). Informe sobre casos de presunta corrupción en el sector salud durante la pandemia.
Contraloría General de la República. (2024). Índice de riesgos de la corrupción e inconducta funcional (INCO 2024).
Cooper, S., (2024). Applying GRADE-CERQual to interpretive review findings: Reflections from a Cochrane meta-ethnography on childhood vaccination acceptance. International Journal of Qualitative Methods, 23, 16094069241246413.
Costa, I. C. P., Mendes, K. D. S., & Freitas, P. S. (2025). Literature search strategies: A guideline for identifying the best evidence in healthcare. Texto & Contexto Enfermagem, 34, e20230405. https://doi.org/10.1590/1980-265X-TCE-2023-0405en
De Cassai, A., (2025). Methodological standards for conducting high-quality systematic reviews. Biology, 14(8), 973.
Elsman, E. B. M., (2024). Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024. Journal of Clinical Epidemiology, 173, 111422. https://doi.org/10.1016/j.jclinepi.2024.111422
Espinoza, L. A., Mallma, P., & García, P. J. (2023). Informal payments in health facilities in Peru in 2018: Analysis of a cross-sectional survey. PLOS Global Public Health, 4(1), e0001837. https://doi.org/10.1371/journal.pgph.0001837
Gaitonde, R., Oxman, A. D., Okebukola, P. O., & Rada, G. (2022). Interventions to reduce corruption in the health sector. Cochrane Database of Systematic Reviews, 2022(9), CD008856. https://doi.org/10.1002/14651858.CD008856.pub3
Gao, J. (2024). Effects of transparent online open procurement on prices, volumes and costs of medicine orders: A quasi-experimental analysis. Health Policy and Planning, 39(2), 201–212. https://doi.org/10.1093/heapol/czaa213
Giltenane, M., (2025). Assessing the reporting quality of published qualitative evidence syntheses in the Cochrane Library. Cochrane Evidence Synthesis and Methods, 3(3), e70023. https://doi.org/10.1002/cesm.70023
Gonzalez-Aquines, S., Alvarez-Mendoza, C., & Ortega-Pena, S. (2023). Public health expenditure and corruption in European and Latin American contexts: Trends and lessons. European Journal of Public Health, 33(2), 321–329. https://doi.org/10.1093/eurpub/ckad023
Hutchinson, E., Balabanova, D., & McKee, M. (2023). We need to talk about corruption in health systems. International Journal of Health Policy and Management, 12, 1–5. https://doi.org/10.34172/ijhpm.2023.7714
Lagisz, M. (2025). A practical guide to evaluating sensitivity of literature search strings for systematic reviews using relative recall. Research Synthesis Methods, 16(1), 1–14.
Lindsay, S. (2011). Systematic reviews and meta-analyses. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 20(1), 57–59.
MacDonald, H. (2024). Searching for studies: A guide to information retrieval for Campbell systematic reviews. Campbell Systematic Reviews, 20(3), e1433. https://doi.org/10.1002/cl2.1433
Mahmud, N. M. (2024). Anti-corruption efforts in the healthcare sector during the COVID-19 pandemic in Malaysia. SAGE Open, 14(2), 21582440241243118.
Naher, N., Hoque, R., Hassan, M. S., Balabanova, D., Adams, A. M., & Ahmed, S. M. (2022). The influence of corruption and governance in the delivery of frontline health care services in low- and middle-income countries. BMC Public Health, 22, 880. https://doi.org/10.1186/s12889-022-13203-0
Ng, Q. X., & Zhou, K. X. (2025). Rethinking reflexivity, replicability and rigour in qualitative research. Medical Humanities. https://doi.org/10.1136/medhum-2025-013293
OECD. (2024). Hacia un sistema nacional de integridad y transparencia en el Perú. OECD Publishing. https://doi.org/10.1787/40db10d7-es
Ortiz-Prado, E. (2023). Corruption in healthcare: Global perspectives and the policy response. Public Health Reviews, 44, 160014. https://doi.org/10.1186/s40985-023-00140- 6
Peters, L. (2022). A systematic review and meta-synthesis of qualitative studies that investigate emotional experiences of staff working in homeless settings. Health & Social Care in the Community, 30(1), 58–72.
Ramírez Cosme, A. G. (2024). La corrupción en el sector salud: Características, algunas de sus tipologías y efectos. Derecho & Sociedad, (62), 1–17.
Real-Delor, R. E. (2025). Perception of professionalism among Latin American physicians in 2024. Anales del Sistema Sanitario de Navarra, 48(1).
Reed, R. B., & Barnett, D. J. (2025). Assessing the quality of biomedical Boolean search strings generated by prompted and unprompted models using ChatGPT. Medical Reference Services Quarterly, 44(1), 31–40.
Schmidt, L. (2020). Data extraction methods for systematic review automation: A living review protocol. F1000Research, 9, 210.
Smith, V., Smith, A., & Carroll, L. (2025). Quality appraisal tools used in qualitative evidence syntheses. Midwifery, 104479.
Terceiro, L. (2025). Research participants’ engagement in digital health interventions. JMIR Research Protocols, 14(1), e65099.
Veroniki, A. A. (2025). Updating the PRISMA reporting guideline for network meta- analysis. Journal of Clinical Epidemiology, 188, 111985.
Williams, C. C., & Martinez-Perez, A. (2021). Informal payments in health care: A global perspective. Health Policy, 125(8), 1059–1067.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Franklin Rouselbel Correa Prieto
This work is licensed under a Creative Commons Attribution 4.0 International License.
